ASCO 2024 AVM0703 Poster #7077: Durable complete response and overall survival in patients with heavily pretreated, poor-prognosis non-Hodgkin lymphoma to immuno-activating AVM0703 with few and mild drug-related adverse effects

ASCO_AVM0703_Poster_7077_2024